Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway

Journal of Neurochemistry

Volumn 127, Issue 3, 2013, Pages 394-402

  Nissen, Jillian C ^a   Selwood, David L ^b   Tsirka, Stella E ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

anti inflammatory; cytokines; microglia; neuropilin 1; tuftsin

Indexed keywords

NEUROPILIN 1; PROTEIN KINASE B; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TUFTSIN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME PHOSPHORYLATION; FEMALE; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANTI-INFLAMMATORY; CYTOKINES; MICROGLIA; NEUROPILIN 1; TUFTSIN;

ANIMALS; BLOTTING, WESTERN; CEREBRAL CORTEX; CYTOKINES; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGIC FACTORS; METHIONINE; MICE; MICE, INBRED C57BL; MICROGLIA; NEURONS; NEUROPILIN-1; NITRIC OXIDE; PRIMARY CELL CULTURE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RNA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUFTSIN;

EID: 84886084918     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12404     Document Type: Article

References (46)

1. Bhasin M., Wu M., and, Tsirka S. E., (2007) Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis. BMC Immunol. 8, 10.
2. Bump N., Lee J., Wleklik M., Reichler J., and, Najjar V., (1986) Isolation and subunit composition of tuftsin receptor. Proc. Natl Acad. Sci. USA 83, 7187-7191.
3. Evans I. M., Yamaji M., Britton G., Pellet-Many C., Lockie C., Zachary I. C., and, Frankel P., (2011) Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells. Mol. Cell. Biol. 31, 1174-1185.
4. Fantin A., Schwarz Q., Davidson K., Normando E. M., Denti L., and, Ruhrberg C., (2011) The cytoplasmic domain of neuropilin 1 is dispensable for angiogenesis, but promotes the spatial separation of retinal arteries and veins. Development 138, 4185-4191.
5. Glinka Y., and, Prud'homme G. J., (2008) Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J. Leukoc. Biol. 84, 302-310.
6. Gordon S., and, Martinez F., (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32, 593-604.
7. Gu C., Rodriguez E. R., Reimert D. V., Shu T., Fritzsch B., Richards L. J., Kolodkin A. L., and, Ginty D. D., (2003) Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev. Cell 5, 45-57.
8. Hains L. E., Loram L. C., Weiseler J. L., et al,. (2010) Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming. J. Pain 11, 1004-1014.
9. Hansen W., (2013) Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma. Oncoimmunology 2, e23039.
10. Jarvis A., Allerston C. K., Jia H., et al,. (2010) Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction. J. Med. Chem. 53, 2215-2226.
11. Jia H., Cheng L., Tickner M., Bagherzadeh A., Selwood D., and, Zachary I., (2010) Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity. Br. J. Cancer 102, 541-552.
12. Karpanen T., Heckman C. A., Keskitalo S., Jeltsch M., Ollila H., Neufeld G., Tamagnone L., and, Alitalo K., (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 20, 1462-1472.
13. Kigerl K., Gensel J., Ankeny D., Alexander J., Donnelly D., and, Popovich P., (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29, 13435-13444.
14. Kitsukawa T., Shimono A., Kawakami A., Kondoh H., and, Fujisawa H., (1995) Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121, 4309-4318.
15. Klagsbrun M., Takashima S., and, Mamluk R., (2002) The role of neuropilin in vascular and tumor biology. Adv. Exp. Med. Biol. 515, 33-48.
16. Kohm A. P., Carpentier P. A., Anger H. A., and, Miller S. D., (2002) Cutting edge: CD4+ CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169, 4712-4716.
17. Lohr J., Knoechel B., Wang J. J., Villarino A. V., and, Abbas A. K., (2006) Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J. Exp. Med. 203, 2785-2791.
18. Luo H., Hao Y., Tang B., Zeng D., Shi Y., and, Yu P., (2012) Mouse forestomach carcinoma cells immunosuppress macrophages through transforming growth factor-beta1. Mol. Med. Rep. 5, 988-992.
19. McGeachy M. J., Stephens L. A., and, Anderton S. M., (2005) Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+ CD25+ regulatory cells within the central nervous system. J. Immunol. 175, 3025-3032.
20. Michelucci A., Heurtaux T., Grandbarbe L., Morga E., and, Heuschling P., (2009) Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J. Neuroimmunol. 210, 3-12.
21. Najjar V. A., and, Nishioka K., (1970) "Tuftsin": a natural phagocytosis stimulating peptide. Nature 228, 672-673.
22. Nishioka K., Sato P. S., Constantopoulos A., and, Najjar V. A., (1973) The chemical synthesis of the phagocytosis-stimulating tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and its biological properties. Biochim. Biophys. Acta 310, 230-237.
23. O'Leary F. M., Tajima G., Delisle A. J., Ikeda K., Dolan S. M., Hanschen M., Mannick J. A., and, Lederer J. A., (2011) Injury-induced GR-1+ macrophage expansion and activation occurs independently of CD4 T-cell influence. Shock 36, 162-169.
24. Prud'homme G. J., and, Glinka Y., (2012) Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity. Oncotarget 3, 921-939.
25. Rahimi R. A., and, Leof E. B., (2007) TGF-beta signaling: a tale of two responses. J. Cell. Biochem. 102, 593-608.
26. Rogove A. D., and, Tsirka S. E., (1998) Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr. Biol. 8, 19-25.
27. Sarris M., Andersen K. G., Randow F., Mayr L., and, Betz A. G., (2008) Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28, 402-413.
28. Shao E. S., Lin L., Yao Y., and, Bostrom K. I., (2009) Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells. Blood 114, 2197-2206.
29. Shiou S. R., Datta P. K., Dhawan P., Law B. K., Yingling J. M., Dixon D. A., and, Beauchamp R. D., (2006) Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta. J. Biol. Chem. 281, 33971-33981.
30. Siao C. J., and, Tsirka S. E., (2002) Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J. Neurosci. 22, 3352-3358.
31. Siddiq M. M., and, Tsirka S. E., (2004) Modulation of zinc toxicity by tissue plasminogen activator. Mol. Cell. Neurosci. 25, 162-171.
32. Siemion I. Z., and, Kluczyk A., (1999) Tuftsin: on the 30-year anniversary of Victor Najjar's discovery. Peptides 20, 645-674.
33. Soker S., Takashima S., Miao H. Q., Neufeld G., and, Klagsbrun M., (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745.
34. Tian M., Neil J. R., and, Schiemann W. P., (2011) Transforming growth factor-beta and the hallmarks of cancer. Cell. Signal. 23, 951-962.
35. Tordjman R., Lepelletier Y., Lemarchandel V., Cambot M., Gaulard P., Hermine O., and, Romeo P. H., (2002) A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat. Immunol. 3, 477-482.
36. Vander Kooi C. W., Jusino M. A., Perman B., Neau D. B., Bellamy H. D., and, Leahy D. J., (2007) Structural basis for ligand and heparin binding to neuropilin B domains. Proc. Natl Acad. Sci. USA 104, 6152-6157.
37. Wardowska A., Dzierzbicka K., Szarynska M., Dabrowska-Szponar M., Wisniewska K., Mysliwski A., and, Trzonkowski P., (2009) Analogues of muramyl dipeptide (MDP) and tuftsin limit infection and inflammation in murine model of sepsis. Vaccine 27, 369-374.
38. Wei J., Duramad O., Perng O. A., Reiner S. L., Liu Y. J., and, Qin F. X., (2007) Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc. Natl Acad. Sci. USA 104, 18169-18174.
39. Weiss J. M., Bilate A. M., Gobert M., et al,. (2012) Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 209: 1723-1742, S1721.
40. Wiesmann C., Fuh G., Christinger H. W., Eigenbrot C., Wells J. A., and, de Vos A. M., (1997) Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91, 695-704.
41. von Wronski M. A., Raju N., Pillai R., et al,. (2006) Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor. J. Biol. Chem. 281, 5702-5710.
42. Wu M., Nissen J. C., Chen E. I., and, Tsirka S. E., (2012) Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis. PLoS ONE 7, e34933.
43. Yao Y., and, Tsirka S. E., (2010) The C terminus of mouse monocyte chemoattractant protein 1 (MCP1) mediates MCP1 dimerization while blocking its chemotactic potency. J. Biol. Chem. 285, 31509-31516.
44. Zhang Y. E., (2009) Non-Smad pathways in TGF-beta signaling. Cell Res. 19, 128-139.
45. Zhou X., Spittau B., and, Krieglstein K., (2012) TGFbeta signalling plays an important role in IL4-induced alternative activation of microglia. J. Neuroinflammation 9, 210.
46. Zou H. Y., Li Q., Lee J. H., et al,. (2012) Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitor. Mol. Cancer Ther. 11, 1036-1047.